The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity.
Open accessAbstract
A cDNA that expresses a receptor for very low density lipoprotein (VLDL) was isolated from a rabbit heart cDNA library and characterized. The deduced amino acid sequence of the cDNA revealed that the cDNA encodes a protein with striking homology to the low density lipoprotein (LDL) receptor. Like the LDL receptor, the mature protein consists of the following five domains spanning 846 amino acids: 328 N-terminal amino acids including an 8-fold repeat of 40 amino acids homologous to the ligand binding repeat of the LDL receptor; 396 amino acid residues homologous to the epidermal growth factor precursor including three cysteine-rich repeats; a region immediately outside of the plasma membrane rich in serines and threonines; 22 amino acids traversing the plasma membrane; and 54 amino acids including the NPVY sequence that is required for clustering of the LDL receptor in coated pits and that projects into the cytoplasm. LDL-receptor-deficient Chinese hamster ovary cells transfected with the cDNA bound and internalized VLDL, beta-migrating VLDL, and intermediate density lipoprotein but did not bind LDL with high affinity. The 3.6- and 9.5-kilobase mRNAs for the VLDL receptor are highly abundant in heart, muscle, and adipose tissue. Barely detectable amounts of the mRNAs were present in liver. Based on the structural features, ligand specificity, and tissue expression of the mRNAs, we suggest that this VLDL receptor may mediate uptake of apolipoprotein E-containing lipoproteins enriched with triglyceride in nonhepatic tissues that are active in fatty acid metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,760
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,978
Bolton, A. E., & Hunter, W. M. (1973) · Biochemical Journal · doi:10.1042/bj1330529 · Cited by 3,254
Southern, P. J., & Berg, P. R. (1982) · PubMed · Cited by 2,740
The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA
Yamamoto, T., Davis, C. G., Brown, M. S., Schneider, W. J., Casey, M. L., Goldstein, J. L., & Russell, D. W. (1984) · Cell · doi:10.1016/0092-8674(84)90188-0 · Cited by 1,382
Self-citationHigh-Efficiency Cloning of Full-Length cDNA
Okayama, H., & Berg, P. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.2.161-170.1982 · Cited by 1,267
Binding and Degradation of Low Density Lipoproteins by Cultured Human Fibroblasts
Goldstein, J. L., & Brown, M. S. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42341-7 · Cited by 1,123
pl Bl5: A cDNA Clone of the Rat mRNA Encoding Cyclophilin
DANIELSON, P. E., FORSS-PETTER, S., BROW, M. A., CALAVETTA, L., DOUGLASS, J., MILNER, R. J., & SUTCLIFFE, J. G. (1988) · DNA · doi:10.1089/dna.1988.7.261 · Cited by 1,020
Chen, W. J., Goldstein, J. L., & Brown, M. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39742-x · Cited by 731
Cited by
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,179
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., Hammer, R. E., Richardson, J. A., & Herz, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80782-5 · Cited by 1,261
Molecular genetics of the LDL receptor gene in familial hypercholesterolemia
Hobbs, H. H., Brown, M. S., & Goldstein, J. L. (1992) · Human Mutation · doi:10.1002/humu.1380010602 · Cited by 921
Reelin Is a Ligand for Lipoprotein Receptors
D'Arcangelo, G., Homayouni, R., Keshvara, L., Rice, D. S., Sheldon, M., & Curran, T. (1999) · Neuron · doi:10.1016/s0896-6273(00)80860-0 · Cited by 808
Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences
Vaziri, N. D. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00099.2005 · Cited by 538
Molecular characteristics of insect vitellogenins and vitellogenin receptors
Sappington, T. W., & S. Raikhel, A. (1998) · Insect Biochemistry and Molecular Biology · doi:10.1016/s0965-1748(97)00110-0 · Cited by 521
Lipoprotein receptors in the nervous system
Herz, J., & Bock, H. H. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135342 · Cited by 457
Trommsdorff, M., Borg, J.-P., Margolis, B., & Herz, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33556 · Cited by 453
Kounnas, M. Z., Moir, R. D., Rebeck, G. W., Bush, A. I., Argraves, W. S., Tanzi, R. E., Hyman, B. T., & Strickland, D. K. (1995) · Cell · doi:10.1016/0092-8674(95)90320-8 · Cited by 401
Human Apolipoprotein E Receptor 2
Kim, D.-H., Iijima, H., Goto, K., Sakai, J., Ishii, H., Kim, H.-J., Suzuki, H., Kondo, H., Saeki, S., & Yamamoto, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8373 · Cited by 384
Self-citationTHE MAMMALIAN LOW-DENSITY LIPOPROTEIN RECEPTOR FAMILY
Hussain, M. M., Strickland, D. K., & Bakillah, A. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.141 · Cited by 377
Fujino, T., Asaba, H., Kang, M.-J., Ikeda, Y., Sone, H., Takada, S., Kim, D.-H., Ioka, R. X., Ono, M., Tomoyori, H., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0133792100 · Cited by 336
Self-citationApo E structure determines VLDL clearance and atherosclerosis risk in mice
Knouff, C., Hinsdale, M. E., Mezdour, H., Altenburg, M. K., Watanabe, M., Quarfordt, S. H., Sullivan, P. M., & Maeda, N. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6172 · Cited by 324
Tufail, M., & Takeda, M. (2009) · Journal of Insect Physiology · doi:10.1016/j.jinsphys.2008.11.007 · Cited by 291
3,400 new expressed sequence tags identify diversity of transcripts in human brain
Adams, M. D., Kerlavage, A. R., Fields, C., & Venter, J. C. (1993) · Nature Genetics · doi:10.1038/ng0793-256 · Cited by 290
Bu, G., Geuze, H. J., Strous, G. J., & Schwartz, A. L. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07221.x · Cited by 274
LDL receptor‐related protein: a multiligand receptor for lipoprotein and proteinase catabolism
Strickland, D. K., Kounnas, M. Z., & Argraves, W. S. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615159 · Cited by 268
Sakai, J., Hoshino, A., Takahashi, S., Miura, Y., Ishii, H., Suzuki, H., Kawarabayasi, Y., & Yamamoto, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42151-x · Cited by 266
Self-citationFrykman, P. K., Brown, M. S., Yamamoto, T., Goldstein, J. L., & Herz, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8453 · Cited by 256
Self-citationLipoprotein receptors: new roles for ancient proteins
Willnow, T. E., Nykjaer, A., & Herz, J. (1999) · Nature Cell Biology · doi:10.1038/14109 · Cited by 181
More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration
Lane-Donovan, C., Philips, G. T., & Herz, J. (2014) · Neuron · doi:10.1016/j.neuron.2014.08.005 · Cited by 158
“The ApoE receptors LRP1, LDLR, and VLDLR all appear toplay a key role in theclearanceofAb.”
InfluentialSalinelli, S., Lo, J.-Y., Mims, M. P., Zsigmond, E., Smith, L. C., & Chan, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.21906 · Cited by 153
Battey, F. D., Gåfvels, M. E., FitzGerald, D. J., Argraves, W. S., Chappell, D. A., Strauss, J. F., & Strickland, D. K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31648-4 · Cited by 150
Tolar, M., Keller, J. N., Chan, S., Mattson, M. P., Marques, M. A., & Crutcher, K. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-16-07100.1999 · Cited by 148
“ApoE binding and internalization, which can be mediated by several structurally related cell surface receptors of the LDL receptor family, including the LDL receptor and LRP (Yamamoto et al., 1984; Herz et al., 1988; Beisiegel et al., 1989; Raychowdhury et al., 1989; Takahasi et al., 1992; Kim et al., 1996; Novak et a…”
Argraves, K. M., Kozarsky, K. F., Fallon, J. T., Harpel, P. C., & Strickland, D. K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119753 · Cited by 146
Differential glycosylation regulates processing of lipoprotein receptors by γ-secretase
May, P., Bock, H. H., Nimpf, J., & Herz, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305858200 · Cited by 142
Bu, G., & Rennke, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.22218 · Cited by 138
Ji, Z.-S., Pitas, R. E., & Mahley, R. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13452 · Cited by 134
Protection From Obesity in Mice Lacking the VLDL Receptor
Goudriaan, J. R., Tacken, P. J., Dahlmans, V. E. H., Gijbels, M. J. J., van Dijk, K. W., Havekes, L. M., & Jong, M. C. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.095147 · Cited by 133
Ji, Z.-S., Dichek, H. L., Miranda, R. D., & Mahley, R. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31285 · Cited by 128
Hu, W., Jiang, A., Liang, J., Meng, H., Chang, B., Gao, H., & Qiao, X. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0870 · Cited by 117
Spuch, C., Ortolano, S., & Navarro, C. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00269 · Cited by 107
Novak, S., Hiesberger, T., Schneider, W. J., & Nimpf, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.20.11732 · Cited by 105
Goudriaan, J. R., Santo, S. M. S. E., Voshol, P. J., Teusink, B., van Dijk, K. W., van Vlijmen, B. J. M., Romijn, J. A., Havekes, L. M., & Rensen, P. C. N. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400009-jlr200 · Cited by 100
“Initial in vitro studies have demonstrated that the VLDLr is a receptor for several apolipoprotein E (apoE)-containing lipoprotein ligands, such as VLDL, intermediate density lipoproteins, and chylomi-crons (2, 4).”
Kim, D.-H., Inagaki, Y., Suzuki, T., Ioka, R. X., Yoshioka, S. Z., Magoori, K., Kang, M.-J., Cho, Y., Nakano, A. Z., Liu, Q., et al. (1998) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022223 · Cited by 99
Self-citationWheal, H. V., Chen, Y., Mitchell, J., Schachner, M., Maerz, W., Wieland, H., van Rossum, D., & Kirsch, J. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00026-4 · Cited by 93
Chen, Y., Hu, Y., Lu, K., Flannery, J. G., & Ma, J.-X. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611289200 · Cited by 92
The Reelin Receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL Receptor
Dlugosz, P., & Nimpf, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103090 · Cited by 91
“The first cDNA for the VLDLR was cloned by Yamamoto and colleagues from a rabbit heart cDNA library as a receptor for apoE containing lipoproteins [28].”
BackgroundObunike, J. C., Lutz, E. P., Li, Z., Paka, L., Katopodis, T., Strickland, D. K., Kozarsky, K. F., Pillarisetti, S., & Goldberg, I. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008813200 · Cited by 91
Medh, J. D., Bowen, S. L., Fry, G. L., Ruben, S., Andracki, M., Inoue, I., Lalouel, J.-M., Strickland, D. K., & Chappell, D. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.29.17073 · Cited by 89
The generation and function of soluble apoE receptors in the CNS
Rebeck, G. W., LaDu, M. J., Estus, S., Bu, G., & Weeber, E. J. (2006) · Molecular Neurodegeneration · doi:10.1186/1750-1326-1-15 · Cited by 66
Obermoeller, L. M., Warshawsky, I., Wardell, M. R., & Bu, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10761 · Cited by 64
Domains of Apolipoprotein E Contributing to Triglyceride and Cholesterol Homeostasis in Vivo
Kypreos, K. E., van Dijk, K. W., van der Zee, A., Havekes, L. M., & Zannis, V. I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100418200 · Cited by 62
LDL Receptor‐Related Proteins in Neurodevelopment
May, P., & Herz, J. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.00086_4_5.x · Cited by 60
Beffert, U., Aumont, N., Dea, D., Lussier‐Cacan, S., Davignon, J., & Poirier, J. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70041458.x · Cited by 59
Ishigaki, Y., Oikawa, S., Suzuki, T., Usui, S., Magoori, K., Kim, D.-H., Suzuki, H., Sasaki, J., Sasano, H., Okazaki, M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005906200 · Cited by 58
Self-citationGuttman, M., Prieto, J. H., Croy, J. E., & Komives, E. A. (2010) · Biochemistry · doi:10.1021/bi9017208 · Cited by 54
Cedazo-Mı́nguez, A., Wiehager, B., Winblad, B., Hüttinger, M., & Cowburn, R. F. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00128-5 · Cited by 50
Mikhailenko, I., Considine, W., Argraves, K. M., Loukinov, D., Hyman, B. T., & Strickland, D. K. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.19.3269 · Cited by 48
Novel insights into the multifaceted and tissue‐specific roles of the endocytic receptor LRP1
Yamamoto, K., Scilabra, S. D., Bonelli, S., Jensen, A., Scavenius, C., Enghild, J. J., & Strickland, D. K. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107521 · Cited by 47
Brandes, C., Novak, S., Stockinger, W., Herz, J., Schneider, W. J., & Nimpf, J. (1997) · Genomics · doi:10.1006/geno.1997.4702 · Cited by 46
Kypreos, K. E., & Zannis, V. I. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500322-jlr200 · Cited by 45
Mulder, M., & Terwel, D. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022429 · Cited by 40
Georgiadou, D., Stamatakis, K., Efthimiadou, E. K., Kordas, G., Gantz, D., Chroni, A., & Stratikos, E. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m030965 · Cited by 37
A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy
Ogawa, T., Maruyama, K., Hattori, H., Arai, H., Kondoh, I., Egashira, T., Watanabe, T., Kobayashi, Y., & Morikawa, A. (2000) · Pediatric Nephrology · doi:10.1007/s004670050032 · Cited by 37
LaDu, M. J., Stine, Narita, M., Getz, G. S., Reardon, C. A., & Bu, G. (2006) · Biochemistry · doi:10.1021/bi051765s · Cited by 36
Keishi-bukuryo-gan prevents the progression of atherosclerosis in cholesterol-fed rabbit
SEKIYA, N., Tanaka, N., Itoh, T., Shimada, Y., Goto, H., & TERASAWA, K. (1999) · Phytotherapy Research · doi:10.1002/(sici)1099-1573(199905)13:3<192::aid-ptr412>3.0.co;2-2 · Cited by 34
Na, H., Yang, J. B., Zhang, Z., Gan, Q., Tian, H., Rajab, I. M., Potempa, L. A., Tao, Q., & Qiu, W. Q. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.02.013 · Cited by 27
Okoro, E. U., Zhao, Y., Guo, Z., Zhou, L., Lin, X., & Yang, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044430 · Cited by 25
“Though the interaction of apoE4 with VLDLR and apoER2 has not been studied in detail, indirect evidence supports the view that apoE4 is deficient in the VLDLR- and/or apoER2-mediated signaling transduction process.”
BackgroundInfluentialMurata, M., Kodama, H., Goto, K., Hirano, H., & Tanaka, T. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70105-9 · Cited by 23
Sakai, K., Tiebel, O., Ljungberg, M. C., Sullivan, M., Lee, H.-J., Terashima, T., Li, R., Kobayashi, K., Lu, H.-C., Chan, L., et al. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.030 · Cited by 23
“…a VLDLR cDNA clone lacking exon 9 that encodes 42 amino acids in the epidermal growth factor precursor homology domain has been reported in mice (Gafvels et al., 1994). β-migrating triglyceride-rich lipoproteins (β-VLDL) are enriched by apoE and are ligands for VLDLR (Takahashi et al., 1992).”
BackgroundInfluentialHuman β-migrating very low density lipoprotein induces foam cell formation in human mesangial cells
Anami, Y., Kobori, S., Sakai, M., Kasho, M., Nishikawa, T., Yano, T., Matsuda, H., Matsumura, T., Takemura, T., & Shichiri, M. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00166-4 · Cited by 16
Vezeridis, A. M., Drosatos, K., & Zannis, V. I. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m008409 · Cited by 11
“Lipoprotein-bound apoE is the ligand for the LDL receptor as well as other receptors in vitro [4-6].”
BackgroundUmans, L., Overbergh, L., Serneels, L., Tesseur, I., & Van Leuven, F. (1999) · Biology of Reproduction · doi:10.1095/biolreprod61.5.1216 · Cited by 9
Larios, J. A., & Marzolo, M.-P. (2012) · Frontiers in Biology · doi:10.1007/s11515-011-1186-7 · Cited by 9
Fotakis, P., Vezeridis, A., Dafnis, I., Chroni, A., Kardassis, D., & Zannis, V. I. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m048348 · Cited by 4
(2012) · Europe PMC (PubMed Central)
Metadata
- Authors
- Takahashi, S., Kawarabayasi, Y., Nakai, T., Sakai, J., & Yamamoto, T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-10
- Volume
- 89
- Issue
- 19
- Pages
- 9252-9256
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1995618009
- Cited by
- 549
- References
- 22
- FWCI
- 33.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.